SHARE-BASED COMPENSATION, Share Options Activity (Details)			6 Months Ended		12 Months Ended
		Dec. 08, 2023	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares		Dec. 31, 2022 USD ($) $ / shares shares
Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]
Share consolidation		0.1
Stock Options [Member]
Number of Share Options [Roll Forward]
Outstanding, beginning balance (in shares) | shares				21,603,366	21,603,366
Option granted (in shares) | shares			0	0
Exercised (in shares) | shares			0	0
Forfeited (in shares) | shares			(82,710)	(152,500)
Expired (in shares) | shares			(146,783)	(40,000)
Outstanding, ending balance (in shares) | shares			1,795,622	21,410,866			21,603,366
Outstanding, beginning balance after share consolidation (in shares) | shares	[1]		2,025,115
Expected to vest, period end (in shares) | shares			452,763
Exercisable, period end (in shares) | shares			1,342,859
Weighted Average Exercise Price [Abstract]
Outstanding, beginning balance (in dollars per share) | $ / shares				$ 1.44	$ 1.44
Granted (in dollars per share) | $ / shares			$ 0	0
Exercised (in dollars per share) | $ / shares			0	0
Forfeited (in dollars per share) | $ / shares			17	1.68
Expired (in dollars per share) | $ / shares			16.81	1.68
Outstanding, ending balance (in dollars per share) | $ / shares			13.92	$ 1.44			$ 1.44
Outstanding, beginning balance after share consolidation (in dollars per share) | $ / shares	[1]		14.26
Expected to vest, period end (in dollars per share) | $ / shares			17.07
Exercisable, period end (in dollars per share) | $ / shares			$ 12.86
Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]
Outstanding, weighted average remaining contractual term			4 years 21 days	5 years 5 months 15 days	4 years 9 months 21 days	[1]	5 years 11 months 26 days
Expected to vest, weighted average remaining contractual term			7 years 7 months 24 days
Exercisable, weighted average remaining contractual term			2 years 10 months 6 days
Outstanding, aggregate intrinsic value | $			$ 0	$ 43,698	$ 0	[1]	$ 721,210
Expected to vest, aggregate intrinsic value | $			0
Exercisable, aggregate intrinsic value | $			$ 0
Share consolidation		0.1

[1] On September 1, 2023 the Company held its annual general meeting of shareholders where among other proposals, the shareholders of the Company did approve the consolidation of the ordinary shares of the Company on a one-for-ten (1:10) basis with effect from December 8, 2023 (the “Share Consolidation”). The one-for-ten reverse stock split decreased the number of outstanding shares and increased net loss per common share. All per share and share amounts presented have been retroactively adjusted for the effect of this share consolidation for all periods presented.